Related Experiment Video
Updated: Aug 14, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Bleeding complications and coagulopathy in acute leukaemia
E Törnebohm1, M Blombäck, D Lockner
1Department of Internal Medicine, Huddinge University Hospital, Sweden.
This study reveals that acute leukemia patients often have coagulation issues, with low protein C, fibrinogen, and platelets linked to major bleeding. Antithrombin levels predict prognosis in these leukemia patients.
Area of Science:
- Hematology
- Oncology
- Clinical Coagulation
Background:
- Acute leukemia frequently presents with coagulation disturbances.
- Hemorrhage is a significant complication in leukemia patients.
- Understanding hemostasis in leukemia is crucial for patient management.
Purpose of the Study:
- To investigate coagulation and fibrinolysis factors in acute leukemia patients.
- To correlate these factors with the incidence of hemorrhage.
- To identify prognostic markers for bleeding complications.
Main Methods:
- Coagulation and fibrinolysis factors were measured on admission in 57 acute leukemia patients.
- Levels of prothrombin complex, fibrinogen, protein C, platelets, antiplasmin, and antithrombin were assessed.
- Von Willebrand factor antigen (vWF:Ag) was correlated with leukaemic cell count.
Main Results:
- 98% of patients exhibited coagulation disturbances.
- Severe thrombocytopenia (< 20 x 10(9)/l) was observed in 16%.
- Patients with major bleeding had significantly lower levels of prothrombin complex, fibrinogen, protein C, and platelets.
- Low antiplasmin and fibrinogen were characteristic in promyelocytic and lymphoblastic leukemia.
- A positive correlation was found between vWF:Ag and leukaemic cell count (ks = 0.72), particularly in lymphoblastic leukemia.
- Reduced antithrombin levels indicated a poorer prognosis.
Conclusions:
- Coagulation disturbances are nearly universal in acute leukemia.
- Specific hemostatic factor deficiencies are associated with major bleeding.
- Leukemia type influences hemostatic profiles.
- Antithrombin levels serve as a prognostic indicator for acute leukemia patients.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management
Hemorrhagic Stroke ll: Pathophysiology

